Next Article in Journal
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
Next Article in Special Issue
In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine Development
Previous Article in Journal
Humoral Immune Response to SARS-CoV-2 Spike Protein Receptor-Binding Motif Linear Epitopes
Previous Article in Special Issue
New Trends in Vaccine Characterization, Formulations, and Development
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 343; https://doi.org/10.3390/vaccines12040343
Action Date Notes Link
article xml file uploaded 22 March 2024 07:22 CET Original file -
article xml uploaded. 22 March 2024 07:22 CET Update https://www.mdpi.com/2076-393X/12/4/343/xml
article pdf uploaded. 22 March 2024 07:22 CET Version of Record https://www.mdpi.com/2076-393X/12/4/343/pdf
article html file updated 22 March 2024 07:23 CET Original file https://www.mdpi.com/2076-393X/12/4/343/html
Back to TopTop